Sansei Capital Investment Co., Ltd.

Overview

Sansei Capital Investment Co., Ltd. is a Japanese venture capital firm specializing in early-stage investments within the biotechnology sector. The firm focuses on providing capital and strategic support to emerging companies in areas such as medical devices, pharmaceuticals, and life sciences. By leveraging its expertise and network, Sansei Capital aims to foster innovation and growth in the biotech industry. The firm's investment strategy encompasses a wide range of stages, including seed, early stage, Series A, Series B, growth, late stage, and pre-IPO. This approach allows Sansei Capital to support companies at various points in their development, from initial concept to market readiness. Geographically, the firm concentrates its efforts within Japan, aligning with its commitment to strengthening the domestic biotech ecosystem. Sansei Capital's portfolio includes a diverse array of companies across multiple industries, reflecting its broad investment interests within the biotechnology sector. The firm's minimum investment size is $1 million, with a maximum of $50 million, enabling it to participate in both smaller and larger funding rounds. Through these investments, Sansei Capital seeks to drive advancements in biotechnology and contribute to the growth of innovative companies in Japan.

Investment Focus

• Innovative biotechnology solutions
• Strong management teams
• Scalable business models
• Potential for significant market impact
• Alignment with Sansei Capital's strategic focus areas

Portfolio Companies